Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.

Michielsen LA, Budding K, Drop D, van de Graaf EA, Kardol-Hoefnagel T, Verhaar MC, van Zuilen AD, Otten HG.

Front Immunol. 2018 Jan 22;8:2008. doi: 10.3389/fimmu.2017.02008. eCollection 2017.

2.

Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation.

Budding K, van Setten J, van de Graaf EA, van Rossum OA, Kardol-Hoefnagel T, Oudijk ED, Hack CE, Otten HG.

Front Immunol. 2017 Sep 6;8:1109. doi: 10.3389/fimmu.2017.01109. eCollection 2017.

3.

Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube Feeding.

Hollander FM, de Roos NM, Belle van Meerkerk G, Teding van Berkhout F, Heijerman HGM, van de Graaf EA.

J Acad Nutr Diet. 2017 Nov;117(11):1808-1815. doi: 10.1016/j.jand.2017.07.006. Epub 2017 Sep 12.

PMID:
28919081
4.

A Multicenter Study on Long-Term Outcomes After Lung Transplantation Comparing Donation After Circulatory Death and Donation After Brain Death.

van Suylen V, Luijk B, Hoek RAS, van de Graaf EA, Verschuuren EA, Van De Wauwer C, Bekkers JA, Meijer RCA, van der Bij W, Erasmus ME.

Am J Transplant. 2017 Oct;17(10):2679-2686. doi: 10.1111/ajt.14339. Epub 2017 May 30.

PMID:
28470870
5.

Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation.

Budding K, Rossato M, van de Graaf EA, Kwakkel-van Erp JM, Radstake TRDJ, Otten HG.

Transpl Immunol. 2017 Jun;42:1-4. doi: 10.1016/j.trim.2017.04.002. Epub 2017 Apr 28.

6.

Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Oudijk ED, Kwakkel-van Erp JM, Hack CE, Otten HG.

Front Immunol. 2017 Mar 21;8:322. doi: 10.3389/fimmu.2017.00322. eCollection 2017.

7.

High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury.

Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, Meulenbelt J.

Eur J Clin Pharmacol. 2017 May;73(5):573-580. doi: 10.1007/s00228-017-2204-8. Epub 2017 Jan 28.

8.

Awake ECMO on the move to lung transplantation: serial monitoring of physical condition.

Hermens JA, Braithwaite SA, Platenkamp M, Wijnandts PR, Van de Graaf EA, van der Kaaij NP, De Jong M, Heijnen G, Janssen J, Kesecioglu J, Donker DW.

Intensive Care Med. 2017 May;43(5):707-708. doi: 10.1007/s00134-016-4667-y. Epub 2017 Jan 23. No abstract available.

PMID:
28116453
9.

Immune status assessment in adult lung transplant candidates.

van Kessel DA, Hoffman TW, van Velzen-Blad H, van de Graaf EA, Grutters JC, Rijkers GT.

Transpl Immunol. 2017 Feb;40:31-34. doi: 10.1016/j.trim.2016.11.001. Epub 2016 Nov 17.

PMID:
27867073
10.

β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.

Vijftigschild LA, Berkers G, Dekkers JF, Zomer-van Ommen DD, Matthes E, Kruisselbrink E, Vonk A, Hensen CE, Heida-Michel S, Geerdink M, Janssens HM, van de Graaf EA, Bronsveld I, de Winter-de Groot KM, Majoor CJ, Heijerman HG, de Jonge HR, Hanrahan JW, van der Ent CK, Beekman JM.

Eur Respir J. 2016 Sep;48(3):768-79. doi: 10.1183/13993003.01661-2015. Epub 2016 Jul 28.

11.

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.

Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, Bronsveld I, van de Graaf EA, Nieuwenhuis EE, Houwen RH, Vleggaar FP, Escher JC, de Rijke YB, Majoor CJ, Heijerman HG, de Winter-de Groot KM, Clevers H, van der Ent CK, Beekman JM.

Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.

PMID:
27334259
12.

Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections.

Belle-van Meerkerk G, de Valk HW, Stam-Slob MC, Teding van Berkhout F, Zanen P, van de Graaf EA.

Diabetes Res Clin Pract. 2016 Jun;116:230-6. doi: 10.1016/j.diabres.2016.04.014. Epub 2016 Apr 27.

PMID:
27321340
13.

Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, Luijk BD, Oudijk EJ, van Kessel DA, Grutters JC, Hack CE, Otten HG.

Sci Rep. 2016 May 24;6:26274. doi: 10.1038/srep26274.

14.

Prediction Equations Underestimate Resting Energy Expenditure in Patients With End-Stage Cystic Fibrosis.

Hollander FM, Kok A, de Roos NM, Belle-van Meerkerk G, van de Graaf EA.

Nutr Clin Pract. 2017 Feb;32(1):116-121. doi: 10.1177/0884533616645819. Epub 2016 Jul 10.

PMID:
27143650
15.

Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients.

Belle-van Meerkerk G, de Jong PA, de Valk HW, Neefjes T, Pameijer FA, Kwakkel-van Erp JM, van de Graaf EA.

PLoS One. 2015 Dec 23;10(12):e0145597. doi: 10.1371/journal.pone.0145597. eCollection 2015.

16.

A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Broen JC, Kwakkel-van Erp JM, Oudijk EJ, van Kessel DA, Hack CE, Otten HG.

Am J Transplant. 2016 Mar;16(3):987-98. doi: 10.1111/ajt.13497. Epub 2015 Oct 30.

17.

Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.

ten Klooster L, Nossent GD, Kwakkel-van Erp JM, van Kessel DA, Oudijk EJ, van de Graaf EA, Luijk B, Hoek RA, van den Blink B, van Hal PT, Verschuuren EA, van der Bij W, van Moorsel CH, Grutters JC.

Lung. 2015 Dec;193(6):919-26. doi: 10.1007/s00408-015-9794-7. Epub 2015 Sep 24.

PMID:
26404700
18.

Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation.

Sikma MA, van Maarseveen EM, van de Graaf EA, Kirkels JH, Verhaar MC, Donker DW, Kesecioglu J, Meulenbelt J.

Am J Transplant. 2015 Sep;15(9):2301-13. doi: 10.1111/ajt.13309. Epub 2015 Jun 4. Review.

19.

Emphysema Is Common in Lungs of Cystic Fibrosis Lung Transplantation Patients: A Histopathological and Computed Tomography Study.

Mets OM, Roothaan SM, Bronsveld I, Luijk B, van de Graaf EA, Vink A, de Jong PA.

PLoS One. 2015 Jun 5;10(6):e0128062. doi: 10.1371/journal.pone.0128062. eCollection 2015.

20.

Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation.

Budding K, van de Graaf EA, Paantjens AW, Kardol-Hoefnagel T, Kwakkel-van Erp JM, van Kessel DA, Otten HG.

Transpl Immunol. 2015 Jun;32(3):195-200. doi: 10.1016/j.trim.2015.03.003. Epub 2015 Apr 2.

PMID:
25841614
21.

Humoral immunity and complement effector mechanisms after lung transplantation.

Budding K, van de Graaf EA, Otten HG.

Transpl Immunol. 2014 Oct;31(4):260-5. doi: 10.1016/j.trim.2014.08.006. Epub 2014 Sep 3. Review.

PMID:
25195091
22.

Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.

Budding K, van de Graaf EA, Hoefnagel T, Kwakkel-van Erp JM, van Kessel DA, Dragun D, Hack CE, Otten HG.

J Cyst Fibros. 2015 Jan;14(1):42-5. doi: 10.1016/j.jcf.2014.07.007. Epub 2014 Aug 2.

23.

Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis.

Budding K, van de Graaf EA, Hoefnagel T, Hack CE, Otten HG.

J Cyst Fibros. 2014 May;13(3):281-8. doi: 10.1016/j.jcf.2013.10.005. Epub 2013 Oct 23.

24.

Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation.

Hollander FM, van Pierre DD, de Roos NM, van de Graaf EA, Iestra JA.

J Cyst Fibros. 2014 Mar;13(2):212-8. doi: 10.1016/j.jcf.2013.08.009. Epub 2013 Sep 13.

25.

YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome.

Kastelijn EA, van Moorsel CH, Ruven HJ, Korthagen NM, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Mar;30(1):28-35.

PMID:
24003532
26.

Crossed wiring closure technique for bilateral transverse thoracosternotomy is associated with less sternal dehiscence after bilateral sequential lung transplantation.

Koster TD, Ramjankhan FZ, van de Graaf EA, Luijk B, van Kessel DA, Meijer RC, Kwakkel-van Erp JM.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):901-5. doi: 10.1016/j.jtcvs.2013.04.033. Epub 2013 Jun 12.

27.

Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients.

Belle-van Meerkerk G, Cramer MJ, Kwakkel-van Erp JM, Nugroho MA, Tahri S, de Valk HW, van de Graaf EA.

J Heart Lung Transplant. 2013 Jun;32(6):609-14. doi: 10.1016/j.healun.2013.03.006. Epub 2013 Apr 9.

PMID:
23582476
28.

Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases.

Belle-van Meerkerk G, van de Graaf EA, Kwakkel-van Erp JM, van Kessel DA, Lammers JW, Biesma DH, de Valk HW.

Diabet Med. 2012 Aug;29(8):e159-62. doi: 10.1111/j.1464-5491.2012.03676.x.

PMID:
22486317
29.

Non-small cell lung carcinoma of donor origin after bilateral lung transplantation.

de Boer M, Vink A, van de Graaf EA.

Lung Cancer. 2012 May;76(2):259-61. doi: 10.1016/j.lungcan.2012.02.010. Epub 2012 Mar 7. No abstract available.

PMID:
22405567
30.

[High mortality in patients with idiopathic pulmonary fibrosis on Dutch lung transplant waiting list].

ten Klooster L, van Moorsel CH, van Hal PT, van den Blink B, Nossent GD, Verschuuren EA, Kwakkel-van Erp JM, van de Graaf EA, van Kessel DA, Grutters JC.

Ned Tijdschr Geneeskd. 2012;156(2):A3752. Dutch.

PMID:
22236616
31.

A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation.

Kastelijn EA, van Moorsel CH, Kazemier KM, Roothaan SM, Ruven HJ, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC.

Fibrogenesis Tissue Repair. 2011 Nov 1;4:24. doi: 10.1186/1755-1536-4-24.

32.

Lung transplantation affects expression of the chemokine receptor type 4 on specific T cell subsets.

Paantjens AW, van de Graaf EA, Kwakkel-van Erp JM, Hoefnagel T, van Kessel DA, van den Bosch JM, Otten HG.

Clin Exp Immunol. 2011 Oct;166(1):103-9. doi: 10.1111/j.1365-2249.2011.04450.x.

33.

The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation.

Paantjens AW, van de Graaf EA, Kwakkel-van Erp JM, Hoefnagel T, van Ginkel WG, Fakhry F, van Kessel DA, van den Bosch JM, Otten HG.

Pulm Med. 2011;2011:432169. doi: 10.1155/2011/432169. Epub 2011 Aug 29.

34.

Mannose-binding lectin deficiency linked to cytomegalovirus (CMV) reactivation and survival in lung transplantation.

Kwakkel-van Erp JM, Paantjens AW, van Kessel DA, Grutters JC, van den Bosch JM, van de Graaf EA, Otten HG.

Clin Exp Immunol. 2011 Sep;165(3):410-6. doi: 10.1111/j.1365-2249.2011.04436.x. Epub 2011 Jun 27.

35.

Chimerism of dendritic cell subsets in peripheral blood after lung transplantation.

Paantjens AW, van de Graaf EA, Heerkens HD, Kwakkel-van Erp JM, Hoefnagel T, van Kessel DA, van den Bosch JM, Otten HG.

J Heart Lung Transplant. 2011 Jun;30(6):691-7. doi: 10.1016/j.healun.2011.01.706. Epub 2011 Mar 9.

PMID:
21388830
36.

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum.

Luijk B, Ekkelenkamp MB, De Jong PA, Kwakkel-van Erp JM, Grutters JC, van Kessel DA, van de Graaf EA.

Case Rep Infect Dis. 2011;2011:460313. doi: 10.1155/2011/460313. Epub 2011 Aug 1.

37.

Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.

Kwakkel-van Erp JM, Haeck IM, Paantjens AW, van de Graaf EA, van Ginkel WG, Knol MJ, de Bruin-Weller MS, Lammers JW, Knol EF, Bruijnzeel-Koomen C, Otten HG.

J Am Acad Dermatol. 2010 Sep;63(3):e70-2. doi: 10.1016/j.jaad.2010.02.015. No abstract available.

PMID:
20708466
38.

Clara cell secretory protein and surfactant protein-D do not predict bronchiolitis obliterans syndrome after lung transplantation.

Paantjens AW, Otten HG, van Ginkel WG, van Kessel DA, van den Bosch JM, Kwakkel-van Erp JM, van de Graaf EA.

Transplantation. 2010 Aug 15;90(3):340-2. doi: 10.1097/TP.0b013e3181e1b9f8. No abstract available.

PMID:
20683434
39.

Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome.

Kastelijn EA, Rijkers GT, Van Moorsel CH, Zanen P, Kwakkel-van Erp JM, Van De Graaf EA, Van Kessel DA, Grutters JC, Van Den Bosch JM.

J Heart Lung Transplant. 2010 Sep;29(9):997-1008. doi: 10.1016/j.healun.2010.04.013. Epub 2010 Jun 8.

PMID:
20627628
40.

Pulmonary embolism and pulmonary infarction after lung transplantation.

Krivokuca I, van de Graaf EA, van Kessel DA, van den Bosch JM, Grutters JC, Kwakkel-van Erp JM.

Clin Appl Thromb Hemost. 2011 Aug;17(4):421-4. doi: 10.1177/1076029610371474. Epub 2010 Jun 13.

PMID:
20547546
41.

Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation.

Kastelijn EA, van Moorsel CH, Ruven HJ, Karthaus V, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC, van den Bosch JM.

J Heart Lung Transplant. 2010 Jun;29(6):680-6. doi: 10.1016/j.healun.2010.01.008. Epub 2010 Mar 29.

PMID:
20347338
42.

Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.

Kastelijn EA, van Moorsel CH, Rijkers GT, Ruven HJ, Karthaus V, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC, van den Bosch JM.

J Heart Lung Transplant. 2010 Jun;29(6):665-71. doi: 10.1016/j.healun.2009.12.013. Epub 2010 Mar 15.

PMID:
20227302
43.

Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.

Paantjens AW, van de Graaf EA, van Ginkel WG, van den Bosch JM, Otten HG.

J Heart Lung Transplant. 2010 May;29(5):596-8. doi: 10.1016/j.healun.2009.10.004. Epub 2010 Mar 5. No abstract available.

PMID:
20207170
44.

[Idiopathic pulmonary fibrosis; description of a Dutch cohort].

Barlo NP, van Moorsel CH, van den Bosch JM, van de Graaf EA, Kwakkel-van Erp JM, Grutters JC.

Ned Tijdschr Geneeskd. 2009;153:B425. Dutch.

PMID:
19785823
45.

Bronchovascular fistula formation after lung transplantation.

van de Graaf EA, Kwakkel-van Erp JM, van Kessel DA, van den Bosch JM, van Oosterhout MF, Vink A.

J Heart Lung Transplant. 2009 May;28(5):531-2. doi: 10.1016/j.healun.2009.01.021. Epub 2009 Mar 14. No abstract available.

PMID:
19416789
46.

[Active donor treatment needed for more organ transplantations].

Nossent GD, Aerdts SJ, Kirkels JH, van de Graaf EA, van Kessel DA, van den Bosch JM, Erasmus ME.

Ned Tijdschr Geneeskd. 2009 Mar 28;153(13):623-7. Dutch. No abstract available.

PMID:
19408541
47.

Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.

Kwakkel-van Erp JM, Otten HG, Paantjens AW, van Kessel DA, van Ginkel WG, van den Bosch JM, van de Graaf EA.

J Heart Lung Transplant. 2008 Oct;27(10):1172-5. doi: 10.1016/j.healun.2008.06.007.

PMID:
18926413
48.

Serum thymus and activation regulated chemokine levels post-lung transplantation as a predictor for the bronchiolitis obliterans syndrome.

Paantjens AW, Kwakkel-van Erp JM, van Ginkel WG, van Kessel DA, van den Bosch JM, van de Graaf EA, Otten HG.

Clin Exp Immunol. 2008 Nov;154(2):202-8. doi: 10.1111/j.1365-2249.2008.03764.x. Epub 2008 Sep 8.

49.

The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.

Kwakkel-van Erp JM, van de Graaf EA, Paantjens AW, van Ginkel WG, Schellekens J, van Kessel DA, van den Bosch JM, Otten HG.

J Heart Lung Transplant. 2008 Sep;27(9):995-1001. doi: 10.1016/j.healun.2008.06.006.

PMID:
18765192
50.

Identification of non-HLA target antigens recognized after lung transplantation.

Otten HG, van den Bosch JM, van Ginkel WG, van Loon M, van de Graaf EA.

J Heart Lung Transplant. 2006 Dec;25(12):1425-30.

PMID:
17178336

Supplemental Content

Loading ...
Support Center